RGT 7.58% 30.5¢ argent biopharma limited

MGC Pharma Catalogues

  1. 453 Posts.
    lightbulb Created with Sketch. 16

    MGC Pharmaceuticals is a publicly traded (ASX: MXC) BioPharma company with a focus on Phytocannabinoid Medications. MGC Pharma has created a seamless, highly-supervised supply chain, for developing Phytocannabinoid medications from seed to sale, with global operations providing proprietary Phytocannabinoid formulations to companies, consumers, researchers and patients worldwide.MGC Pharma’s medications (currently in clinical trials) for treatment areas such as Neurology, Oncology and Auto-Immune (Anti-Inflammatory), all emerge from this pipeline, with the list continuing to grow as more research materializes. With research activities in various fields in Europe, Australia and Israel, MGC Pharma intends to impact global health and wellness via the judicious use of Phytocannabinoids across multiple markets.


    Pharma_ProductCatalogue.pdf

 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
-0.025(7.58%)
Mkt cap ! $14.76M
Open High Low Value Volume
30.0¢ 30.5¢ 30.0¢ $1.48K 4.929K

Buyers (Bids)

No. Vol. Price($)
1 3000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 823 3
View Market Depth
Last trade - 15.11pm 30/08/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.